KORU Medical Systems, Inc. (KRMD) has a MoatMap StockRank of 39/100 based on Quality (51/100), Value (35/100), and Momentum (39/100) factor scores. The current signal is HOLD. KORU Medical Systems manufactures subcutaneous infusion systems. While it has a niche, it is a micro-cap with limited scale and does not align with our high-conviction CDMO pricing power theme.
KORU Medical Systems, Inc. designs, manufactures, and markets innovative medical devices and supplies for subcutaneous infusion, including the FREEDOM Infusion System. The company holds a strong position in the niche market of subcutaneous infusion, offering specialized and patient-friendly solutions that enhance convenience and adherence for chronic care patients. KORU Medical is a specialized healthcare device company, focusing on improving the quality of life for patients requiring regular subcutaneous infusions through its innovative delivery systems.
| Price | $4.00 |
| Market Cap | $192M |
| P/E (Forward) | 51.75 |
| Price/Book | 11.28 |
| Return on Equity | -13.7% |
| Return on Invested Capital | -14.9% |
| Debt/Equity | 19.89 |
| Gross Margin | 61.9% |
| Operating Margin | -7.4% |
| Revenue Growth | 22.1% |
| Free Cash Flow | $874K |
KORU Medical Systems, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).